Industry Focus

Promo: GW Pharmaceuticals scores a big thumbs up from a panel of FDA experts for its marijuana-based drug. Plus, Biogen pays a $1 billion dollars for expanded access to Ionis’ novel pipeline.

Direct download: IF_heathlcare_04.25.2018.mp3
Category:Podcast -- posted at: 3:30pm EST